IPO
Healthcare
Fosun-controlled Gland Pharma's IPO gets off to slow start
The initial public offering of drugmaker Gland Pharma Ltd got off to a slow start on the first day on ......
Healthcare
GIC, hedge funds among anchor investors in Gland Pharma IPO
Drugmaker Gland Pharma Ltd, the first Indian company controlled by a Chinese firm to float an initial public offering, has ......
Markets
How billionaire Jack Ma fell to earth and took Ant's mega IPO with him
They say talk is cheap. Tell that to Jack Ma. Corporate China's shiniest star was just days away from seeing his ......
Finance
Big fees and bragging rights lost: Ant Group bankers hit by shock IPO suspension
The eleventh-hour halt to Ant Group's record $37 billion listing has not only hurt the firm, but also lead bank ......
Healthcare
Fosun-controlled Gland Pharma seeking $3.3 bn valuation in IPO
Drugmaker Gland Pharma Ltd, the first Indian company controlled by a Chinese firm to float an initial public offering, is ......
TMT
Ant Group's $37 bn IPO suspended in Shanghai and Hong Kong
Ant Group's $37 billion stock market listing has been suspended in both Shanghai and Hong Kong in a dramatic move ......
Finance
Equitas Small Finance Bank falls on stock market debut
Equitas Small Finance Bank, a unit of Equitas Holdings Ltd, made a weak debut on the stock exchanges on Monday ......
TMT
Ant Group IPO's Shanghai retail book gets bids for almost $600 bn
The domestic retail book of Ant Group Co Ltd's $34.4 billion dual listing was 872 times oversubscribed as individual investors ......
Infrastructure
Why the work-from-home threat has ended up as just a blip on office market's radar
As the country went into a coronavirus-induced lockdown and opened arms for work from home (WFH) early this year, the ......
Healthcare
Fosun-controlled Gland Pharma gets SEBI nod to float IPO
Gland Pharma Ltd, majority owned by China’s Shanghai Fosun Pharmaceutical Group, has received regulatory nod to go public in what ......